154 related articles for article (PubMed ID: 33963938)
1. Association between cytoreductive nephrectomy and survival among patients with metastatic renal cell carcinoma receiving modern therapies: a systematic review and meta-analysis examining effect modification according to systemic therapy approach.
Hall ME; Bhindi B; Luckenbaugh AN; Laviana AA; Moses KA; Satkunasivam R; Rini B; Klaassen Z; Wallis CJD
Cancer Causes Control; 2021 Jul; 32(7):675-680. PubMed ID: 33963938
[TBL] [Abstract][Full Text] [Related]
2. Improved survival after cytoreductive nephrectomy for metastatic renal cell carcinoma in the contemporary immunotherapy era: An analysis of the National Cancer Database.
Singla N; Hutchinson RC; Ghandour RA; Freifeld Y; Fang D; Sagalowsky AI; Lotan Y; Bagrodia A; Margulis V; Hammers HJ; Woldu SL
Urol Oncol; 2020 Jun; 38(6):604.e9-604.e17. PubMed ID: 32253116
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive nephrectomy in metastatic renal cell carcinoma.
Dahm P; Ergun O; Uhlig A; Bellut L; Risk MC; Lyon JA; Kunath F
Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013773. PubMed ID: 38847285
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Takemura K; Ernst MS; Navani V; Wells JC; Bakouny Z; Donskov F; Basappa NS; Wood LA; Meza L; Pal SK; Szabados B; Powles T; Beuselinck B; McKay RR; Lee JL; Ernst DS; Kapoor A; Yuasa T; Choueiri TK; Heng DYC
Eur Urol Oncol; 2024 Jun; 7(3):501-508. PubMed ID: 37914579
[TBL] [Abstract][Full Text] [Related]
5. Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic Therapies.
Sawaya GB; Dragomir A; Wood LA; Kollmannsberger C; Basappa NS; Kapoor A; Soulières D; Finelli A; Heng DYC; Castonguay V; Canil C; Winquist E; Graham J; Bjarnason GA; Bhindi B; Lalani AK; Pouliot F; Breau RH; Saleh R; Tanguay S
Eur Urol Oncol; 2024 Jun; 7(3):570-580. PubMed ID: 38097481
[TBL] [Abstract][Full Text] [Related]
6. A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomy.
Gross EE; Li M; Yin M; Orcutt D; Hussey D; Trott E; Holt SK; Dwyer ER; Kramer J; Oliva K; Gore JL; Schade GR; Lin DW; Tykodi SS; Hall ET; Thompson JA; Parikh A; Yang Y; Collier KA; Miah A; Mori-Vogt S; Hinkley M; Mortazavi A; Monk P; Folefac E; Clinton SK; Psutka SP
Urol Oncol; 2023 Jan; 41(1):51.e25-51.e31. PubMed ID: 36441070
[TBL] [Abstract][Full Text] [Related]
7. Deferred cytoreductive nephrectomy in the management of metastatic renal cell carcinoma: A systematic review and meta-analysis.
Britton CJ; Andrews JR; Wallis CJD; Sharma V; Leibovich BC; Thompson RH; Boorjian SA; Bhindi B; Costello BA
Urol Oncol; 2023 Mar; 41(3):125-136. PubMed ID: 38832909
[TBL] [Abstract][Full Text] [Related]
8. Outcome benefits of upfront cytoreductive nephrectomy for patients with metastatic renal cell carcinoma: An analysis of the TriNetX database.
Lai GS; Li JR; Wang SS; Chen CS; Yang CK; Lin CY; Hung SC; Chiu KY; Yang SF
PLoS One; 2024; 19(3):e0299102. PubMed ID: 38547226
[TBL] [Abstract][Full Text] [Related]
9. Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy.
Meagher MF; Minervini A; Mir MC; Cerrato C; Rebez G; Autorino R; Hampton L; Campi R; Kriegmair M; Linares E; Hevia V; Musquera M; D'Anna M; Roussel E; Albersen M; Pavan N; Claps F; Antonelli A; Marchioni M; Paksoy N; Erdem S; Derweesh IH
Eur Urol Open Sci; 2024 May; 63():71-80. PubMed ID: 38572300
[TBL] [Abstract][Full Text] [Related]
10. Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive Nephrectomy.
Nicaise EH; Schmeusser BN; Ali A; Midenberg E; Palacios AR; Hartsoe B; Kearns E; Ambadi S; Patil DH; Joshi SS; Narayan VM; Psutka SP; Nazha B; Brown JT; Ogan K; Bilen MA; Master VA
Clin Genitourin Cancer; 2024 Jun; 22(3):102056. PubMed ID: 38443295
[TBL] [Abstract][Full Text] [Related]
11. Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma.
Bex A; Albiges L; Ljungberg B; Bensalah K; Dabestani S; Giles RH; Hofmann F; Hora M; Kuczyk MA; Lam TB; Marconi L; Merseburger AS; Fernández-Pello S; Tahbaz R; Abu-Ghanem Y; Staehler M; Volpe A; Powles T
Eur Urol; 2018 Dec; 74(6):805-809. PubMed ID: 30177291
[TBL] [Abstract][Full Text] [Related]
12. A commentary on 'The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in the targeted therapy and immunological therapy era: a systematic review and meta-analysis' [Int J Surg (2023) 109:982-994].
Wang Q; Shi H; Sun Y; Feng W; Xu H; Wang H
Int J Surg; 2024 Apr; 110(4):2458-2459. PubMed ID: 38668669
[No Abstract] [Full Text] [Related]
13. Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study).
Fiala O; Buti S; Bamias A; Massari F; Pichler R; Maruzzo M; Grande E; De Giorgi U; Molina-Cerrillo J; Seront E; Calabrò F; Myint ZW; Facchini G; Kopp RM; Berardi R; Kucharz J; Vitale MG; Pinto A; Formisano L; Büttner T; Messina C; Monteiro FSM; Battelli N; Kanesvaran R; Büchler T; Kopecký J; Santini D; Giudice GC; Porta C; Santoni M
Target Oncol; 2024 May; ():. PubMed ID: 38704759
[TBL] [Abstract][Full Text] [Related]
14. Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC.
Das A; Shapiro DD; Craig JK; Abel EJ
Nat Rev Urol; 2023 Nov; 20(11):654-668. PubMed ID: 37400492
[TBL] [Abstract][Full Text] [Related]
15. Re: Kosuke Takemura, Matthew S. Ernst, Vishal Navani, et al. Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.002.
Ishiyama Y; Urabe F
Eur Urol Oncol; 2024 Jun; 7(3):642-643. PubMed ID: 38238222
[No Abstract] [Full Text] [Related]
16. Development of a Nomogram Model to Identify Appropriate Candidates from Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Based on the Surveillance, Epidemiology and End Results Database.
Ren K; Ning H; Wu HH; Wu F; Lyu JJ
Clin Genitourin Cancer; 2024 Jun; 22(3):102062. PubMed ID: 38548487
[TBL] [Abstract][Full Text] [Related]
17. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features.
Abel EJ; Master VA; Spiess PE; Raman JD; Shapiro DD; Sexton WJ; Zemp L; Patil D; Lauer K; Allen GO; Matin SF; Karam JA
Eur Urol Oncol; 2024 Apr; 7(2):266-274. PubMed ID: 37442673
[TBL] [Abstract][Full Text] [Related]
18. Safety of presurgical targeted therapy in the setting of metastatic renal cell carcinoma.
Chapin BF; Delacroix SE; Culp SH; Nogueras Gonzalez GM; Tannir NM; Jonasch E; Tamboli P; Wood CG
Eur Urol; 2011 Nov; 60(5):964-71. PubMed ID: 21621907
[TBL] [Abstract][Full Text] [Related]
19. The difficulty in selecting patients for cytoreductive nephrectomy: An evaluation of previously described predictive models.
Manley BJ; Tennenbaum DM; Vertosick EA; Hsieh JJ; Sjoberg DD; Assel M; Benfante NE; Strope SA; Kim E; Casuscelli J; Becerra MF; Coleman JA; Hakimi AA; Russo P
Urol Oncol; 2017 Jan; 35(1):35.e1-35.e5. PubMed ID: 27567689
[TBL] [Abstract][Full Text] [Related]
20. Beyond the knife: strategic patient selection for cytoreductive nephrectomy.
Brönimann S; Ged Y; Singla N
Curr Opin Urol; 2024 May; 34(3):210-216. PubMed ID: 38240477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
